Jon S. Abramson

4.1k total citations · 1 hit paper
66 papers, 2.8k citations indexed

About

Jon S. Abramson is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Jon S. Abramson has authored 66 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 15 papers in Infectious Diseases and 13 papers in Microbiology. Recurrent topics in Jon S. Abramson's work include Influenza Virus Research Studies (17 papers), Bacterial Infections and Vaccines (12 papers) and Vaccine Coverage and Hesitancy (10 papers). Jon S. Abramson is often cited by papers focused on Influenza Virus Research Studies (17 papers), Bacterial Infections and Vaccines (12 papers) and Vaccine Coverage and Hesitancy (10 papers). Jon S. Abramson collaborates with scholars based in United States, Canada and South Africa. Jon S. Abramson's co-authors include Elaine L. Mills, Paul G. Quie, G. Scott Giebink, Harrell W. Chesson, Geoff P. Garnett, Eileen M. Dunne, Herschel W. Lawson, Lauri E. Markowitz, Janet R. Gilsdorf and Larry Pickering and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Investigation.

In The Last Decade

Jon S. Abramson

65 papers receiving 2.6k citations

Hit Papers

ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES 2006 2026 2012 2019 2006 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES
    2006 648 citations Jon S. Abramson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon S. Abramson United States 26 1.6k 676 615 417 397 66 2.8k
George D. Wendel United States 37 1.4k 0.9× 940 1.4× 696 1.1× 877 2.1× 169 0.4× 142 4.2k
Philip Rhodes United States 30 1.6k 1.0× 290 0.4× 1.5k 2.5× 295 0.7× 565 1.4× 55 3.9k
Andrew L. Baughman United States 29 1.8k 1.1× 880 1.3× 712 1.2× 215 0.5× 504 1.3× 57 3.1k
Hannah Christensen United Kingdom 21 1.5k 0.9× 1.1k 1.7× 458 0.7× 211 0.5× 406 1.0× 74 2.5k
William Atkinson United States 18 1.4k 0.9× 238 0.4× 709 1.2× 249 0.6× 899 2.3× 36 2.6k
Begoña Martínez de Tejada Switzerland 29 1.1k 0.7× 373 0.6× 485 0.8× 583 1.4× 208 0.5× 136 2.5k
Jeanne S. Sheffield United States 38 2.6k 1.6× 727 1.1× 1.0k 1.6× 1.8k 4.3× 346 0.9× 175 5.1k
Mark M. Blatter United States 32 3.1k 2.0× 925 1.4× 540 0.9× 222 0.5× 343 0.9× 84 4.2k
Richard H. Beigi United States 28 1.1k 0.7× 612 0.9× 519 0.8× 728 1.7× 520 1.3× 93 2.7k
Paula Ray United States 30 4.2k 2.6× 1.9k 2.9× 623 1.0× 315 0.8× 753 1.9× 47 5.2k

Countries citing papers authored by Jon S. Abramson

Since Specialization
Citations

This map shows the geographic impact of Jon S. Abramson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon S. Abramson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon S. Abramson more than expected).

Fields of papers citing papers by Jon S. Abramson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon S. Abramson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon S. Abramson. The network helps show where Jon S. Abramson may publish in the future.

Co-authorship network of co-authors of Jon S. Abramson

This figure shows the co-authorship network connecting the top 25 collaborators of Jon S. Abramson. A scholar is included among the top collaborators of Jon S. Abramson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon S. Abramson. Jon S. Abramson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neels, Pieter, James F. Southern, Jon S. Abramson, et al.. (2017). Off-label use of vaccines. Vaccine. 35(18). 2329–2337. 19 indexed citations
2.
O’Brien, Katherine L., Fred Binka, Kevin Marsh, & Jon S. Abramson. (2016). Mind the gap: jumping from vaccine licensure to routine use. The Lancet. 387(10031). 1887–1889. 17 indexed citations
3.
Jafri, Rabab, Asad Ali, Nancy E. Messonnier, et al.. (2013). Global epidemiology of invasive meningococcal disease. Population Health Metrics. 11(1). 17–17. 283 indexed citations
4.
Ortiz, Justin R., Kathleen M. Neuzil, Vincent I. Ahonkhai, et al.. (2012). Translating vaccine policy into action: A report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. Vaccine. 30(50). 7134–7140. 21 indexed citations
5.
Shetty, Avinash K., Gregory A. Ross, Thomas Pranikoff, et al.. (2011). Oseltamivir‐resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient. Pediatric Transplantation. 16(5). E153–7. 16 indexed citations
6.
Abramson, Jon S., Jon R. Almquist, Renée R. Jenkins, et al.. (2008). Prioritisation of routine vaccines: a mistake for the USA. The Lancet. 371(9616). 881–882. 2 indexed citations
7.
Gellin, Bruce G., John F. Modlin, Jon S. Abramson, Kathleen M. Neuzil, & Susan Tamblyn. (2005). Annual Universal Influenza Vaccination: Ready or Not?. Clinical Infectious Diseases. 42(1). 132–135. 12 indexed citations
8.
Woods, Charles R. & Jon S. Abramson. (2005). The Next Influenza Pandemic: Will we be Ready to Care for Our Children?. The Journal of Pediatrics. 147(2). 147–155. 9 indexed citations
9.
Abramson, Jon S., et al.. (2003). Coxsackie B1 infection associated with ventriculitis. The Pediatric Infectious Disease Journal. 22(8). 750–751. 4 indexed citations
10.
Abramson, Jon S.. (2002). US Immunization Policy. JAMA. 287(4). 505–505. 42 indexed citations
11.
Abramson, Jon S.. (1999). INTRANASAL, COLD-ADAPTED, LIVE, ATTENUATED INFLUENZA VACCINE. The Pediatric Infectious Disease Journal. 18(12). 1103–1104. 11 indexed citations
12.
Abramson, Jon S. & Laurence B. Givner. (1999). ROCKY MOUNTAIN SPOTTED FEVER. The Pediatric Infectious Disease Journal. 18(6). 539–540. 11 indexed citations
13.
Washburn, Lisa K., et al.. (1993). Response to Haemophilus influenzae type bconjugate vaccine in chronically ill premature infants. The Journal of Pediatrics. 123(5). 791–794. 33 indexed citations
14.
Sherertz, Robert J., Kenneth D. Hampton, Michael A. Pfaller, et al.. (1992). Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unit. The Journal of Pediatrics. 120(3). 455–461. 82 indexed citations
15.
Liu, William J. & Jon S. Abramson. (1990). INACTIVATED POLIO VACCINE FOR PREMATURE INFANTS. The Pediatric Infectious Disease Journal. 9(6). 458–458. 1 indexed citations
16.
Givner, Laurence B., Jon S. Abramson, & Benedict L. Wasilauskas. (1989). Meningitis Due to Haemophilus influenzae Type b Resistant to Ampicillin and Chloramphenicol. Clinical Infectious Diseases. 11(2). 329–334. 18 indexed citations
17.
Abramson, Jon S., et al.. (1988). Alterations in cell protein phosphorylation in human neutrophils exposed to influenza A virus. A possible mechanism for depressed cellular end-stage functions.. The Journal of Immunology. 140(10). 3560–3567. 15 indexed citations
18.
Abramson, Jon S.. (1988). The Pathogenesis of Bacterial Infections in Infants and Children: The Role of Viruses. Perspectives in biology and medicine. 32(1). 63–72. 12 indexed citations
19.
Marks, Warren A., Harris R. Stutman, Melvin I. Marks, et al.. (1986). Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: A multicenter randomized controlled trial. The Journal of Pediatrics. 109(1). 123–130. 38 indexed citations
20.
Wheeler, J. Gary, Robert Boyle, & Jon S. Abramson. (1983). Candida tropicalis pyelonephritis successfully treated with 5-fluorocytosine and surgery. The Journal of Pediatrics. 102(4). 627–629. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George D. Wendel Breakdown of academic impact, for papers by Philip Rhodes Breakdown of academic impact, for papers by Andrew L. Baughman Breakdown of academic impact, for papers by Hannah Christensen Breakdown of academic impact, for papers by William Atkinson Breakdown of academic impact, for papers by Begoña Martínez de Tejada Breakdown of academic impact, for papers by Jeanne S. Sheffield Breakdown of academic impact, for papers by Mark M. Blatter Breakdown of academic impact, for papers by Richard H. Beigi Breakdown of academic impact, for papers by Paula Ray
Rankless by CCL
2026